Source: International Congress 2019 – Metabolic alterations in lung ageing and disease
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
C. Wheelock (Stockholm, Sweden). Metabolic profiling in pulmonary diseases. International Congress 2019 – Metabolic alterations in lung ageing and disease

Member's Comments

No comment yet.

Related content which might interest you: Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pulmonary diseases and ageing Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020 Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Metabolic syndrome and chronic diseases in COPD Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Metabolic syndrome in chronic obstructive pulmonary disease Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 microRNA profiling in pulmonary fibroblasts in COPD Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Metabolic profiling of severe asthma: implications for phenotyping and treatment Source: ERS Lung Science Conference 2020 Year: 2020 Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Source: Eur Respir Monogr 2020; 88: 167-183 Year: 2020 Differential lipopolysaccharide-induced gene expression profile in peripheral blood mononuclear cells of patients with severe asthma and chronic obstructive pulmonary disease Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Pulmonary manifestations of endocrine and metabolic disorders Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=234 Year: 2005 Metabolic changes in lung ageing and COPD Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Use of pulmonary proteomics to investigate lung disease Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004